Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, targeted, small molecule therapies for the treatment of devastating ...
This is a preview. Log in through your library . Abstract Particular thiols of the myosin subfragment 1 moieties of single glycerinated muscle fibers are covalently labeled with rhodamine. By using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback